A detailed history of Wallace Capital Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Wallace Capital Management Inc. holds 644 shares of AMGN stock, worth $176,076. This represents 0.03% of its overall portfolio holdings.

Number of Shares
644
Previous 644 -0.0%
Holding current value
$176,076
Previous $201,000 2.99%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $169,211 - $205,635
644 New
644 $201,000
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $153,810 - $203,994
-844 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $159,693 - $205,260
844 New
844 $203,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wallace Capital Management Inc. Portfolio

Follow Wallace Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wallace Capital Management Inc. with notifications on news.